How much is the Irritable Bowel Syndrome Market market?

The irritable bowel syndrome market market size is estimated to grow at $$ 1931.9 mn in 2023. Read More

What is the growth rate of the Irritable Bowel Syndrome Market market?

The growth rate of the irritable bowel syndrome market year-over-year is 9.3%. Read More

Which region held the largest market share in the Irritable Bowel Syndrome Market market?

North America is the region to held the largest market share with 39% growth. Read More

Who are the key players in the Irritable Bowel Syndrome Market market?

Abbott Laboratories, AbbVie Inc., Alfasigma Spa, Astellas Pharma Inc., AstraZeneca Plc, Bausch Health Companies Inc., Bayer AG, Boehringer Ingelheim International GmbH, GlaxoSmithKline Plc, Ironwood Pharmaceuticals .... Read More

Which Segment has the largest market share in the Irritable Bowel Syndrome Market market?

Type is the segment that has the largest market share in the market. Read More

Irritable Bowel Syndrome Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, China, Germany, Japan, UK, India, France, Canada, Australia, Brazil - Size and Forecast 2024-2028

Published: Nov 2024
Pages: 209
SKU: IRTNTR72042

Enjoy complimentary customisation on priority with our Enterprise License!

Irritable Bowel Syndrome Market Size and Trends

The irritable bowel syndrome market size is forecast to increase by USD 1.93 billion at a CAGR of 9.3% between 2024 and 2028. The Irritable Bowel Syndrome (IBS) market is experiencing significant growth due to the rising prevalence of this condition, particularly among those with moderate-to-severe cases. According to epidemiological studies, IBS affects an estimated 10-15% of the global population, with women being more prone than men. The market is witnessing an increasing number of drug approvals for small molecules to address the unmet needs of patients with diarrhea-predominant, mixed stool pattern, Biologic Therapeutics, and unspecified IBS. However, the challenge of managing side effects associated with existing medications remains a significant concern. Clinical trials are underway to develop more effective and safer treatment options. Reimbursement policies and patient management strategies also play a crucial role in the market's growth. In the US, the IBS market is expected to continue its expansion, driven by the increasing awareness and medical diagnostic of the condition, as well as the growing demand for effective treatment options.

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Drug Class
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation

2.3 Factors of disruption
- Overview on factors of disruption

2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market

3.2 Market characteristics
- Market characteristics analysis

3.3 Value chain analysis
- Value Chain Analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition

4.2 Market segment analysis
- Market segments

4.3 Market size 2023

4.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)

5 Historic Market Size

5.1 Global Irritable Bowel Syndrome Market 2018 - 2022
- Historic Market Size - Data Table on Global Irritable Bowel Syndrome Market 2018 - 2022 ($ million)

5.2 Type segment analysis 2018 - 2022
- Historic Market Size - Type Segment 2018 - 2022 ($ million)

5.3 Drug Class segment analysis 2018 - 2022
- Historic Market Size - Drug Class Segment 2018 - 2022 ($ million)

5.4 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)

5.5 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)

6 Qualitative Analysis

6.1 Impact of AI on the Global Irritable Bowel Syndrome Market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028

7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028

7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028

7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028

7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028

7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028

7.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028

8 Market Segmentation by Type

8.1 Market segments
- Chart on Type - Market share 2023-2028 (%)
- Data Table on Type - Market share 2023-2028 (%)

8.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type

8.3 IBS-D - Market size and forecast 2023-2028
- Chart on IBS-D - Market size and forecast 2023-2028 ($ million)
- Data Table on IBS-D - Market size and forecast 2023-2028 ($ million)
- Chart on IBS-D - Year-over-year growth 2023-2028 (%)
- Data Table on IBS-D - Year-over-year growth 2023-2028 (%)

8.4 IBS-C - Market size and forecast 2023-2028
- Chart on IBS-C - Market size and forecast 2023-2028 ($ million)
- Data Table on IBS-C - Market size and forecast 2023-2028 ($ million)
- Chart on IBS-C - Year-over-year growth 2023-2028 (%)
- Data Table on IBS-C - Year-over-year growth 2023-2028 (%)

8.5 IBS-M - Market size and forecast 2023-2028
- Chart on IBS-M - Market size and forecast 2023-2028 ($ million)
- Data Table on IBS-M - Market size and forecast 2023-2028 ($ million)
- Chart on IBS-M - Year-over-year growth 2023-2028 (%)
- Data Table on IBS-M - Year-over-year growth 2023-2028 (%)

8.6 Market opportunity by Type
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)

9 Market Segmentation by Drug Class

9.1 Market segments
- Chart on Drug Class - Market share 2023-2028 (%)
- Data Table on Drug Class - Market share 2023-2028 (%)

9.2 Comparison by Drug Class
- Chart on Comparison by Drug Class
- Data Table on Comparison by Drug Class

9.3 Antibiotics - Market size and forecast 2023-2028
- Chart on Antibiotics - Market size and forecast 2023-2028 ($ million)
- Data Table on Antibiotics - Market size and forecast 2023-2028 ($ million)
- Chart on Antibiotics - Year-over-year growth 2023-2028 (%)
- Data Table on Antibiotics - Year-over-year growth 2023-2028 (%)

9.4 Guanylate cyclase-C agonists - Market size and forecast 2023-2028
- Chart on Guanylate cyclase-C agonists - Market size and forecast 2023-2028 ($ million)
- Data Table on Guanylate cyclase-C agonists - Market size and forecast 2023-2028 ($ million)
- Chart on Guanylate cyclase-C agonists - Year-over-year growth 2023-2028 (%)
- Data Table on Guanylate cyclase-C agonists - Year-over-year growth 2023-2028 (%)

9.5 Mu-opioid receptor agonists - Market size and forecast 2023-2028
- Chart on Mu-opioid receptor agonists - Market size and forecast 2023-2028 ($ million)
- Data Table on Mu-opioid receptor agonists - Market size and forecast 2023-2028 ($ million)
- Chart on Mu-opioid receptor agonists - Year-over-year growth 2023-2028 (%)
- Data Table on Mu-opioid receptor agonists - Year-over-year growth 2023-2028 (%)

9.6 Chloride channel activators - Market size and forecast 2023-2028
- Chart on Chloride channel activators - Market size and forecast 2023-2028 ($ million)
- Data Table on Chloride channel activators - Market size and forecast 2023-2028 ($ million)
- Chart on Chloride channel activators - Year-over-year growth 2023-2028 (%)
- Data Table on Chloride channel activators - Year-over-year growth 2023-2028 (%)

9.7 Others - Market size and forecast 2023-2028
- Chart on Others - Market size and forecast 2023-2028 ($ million)
- Data Table on Others - Market size and forecast 2023-2028 ($ million)
- Chart on Others - Year-over-year growth 2023-2028 (%)
- Data Table on Others - Year-over-year growth 2023-2028 (%)

9.8 Market opportunity by Drug Class
- Market opportunity by Drug Class ($ million)
- Data Table on Market opportunity by Drug Class ($ million)

10 Customer Landscape

10.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

11 Geographic Landscape

11.1 Geographic segmentation
- Chart on Market share by geography 2023-2028 (%)
- Data Table on Market share by geography 2023-2028 (%)

11.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison

11.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)

11.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)

11.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)

11.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)

11.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)

11.8 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ million)
- Data Table on China - Market size and forecast 2023-2028 ($ million)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)

11.9 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)

11.10 Japan - Market size and forecast 2023-2028
- Chart on Japan - Market size and forecast 2023-2028 ($ million)
- Data Table on Japan - Market size and forecast 2023-2028 ($ million)
- Chart on Japan - Year-over-year growth 2023-2028 (%)
- Data Table on Japan - Year-over-year growth 2023-2028 (%)

11.11 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)

11.12 India - Market size and forecast 2023-2028
- Chart on India - Market size and forecast 2023-2028 ($ million)
- Data Table on India - Market size and forecast 2023-2028 ($ million)
- Chart on India - Year-over-year growth 2023-2028 (%)
- Data Table on India - Year-over-year growth 2023-2028 (%)

11.13 France - Market size and forecast 2023-2028
- Chart on France - Market size and forecast 2023-2028 ($ million)
- Data Table on France - Market size and forecast 2023-2028 ($ million)
- Chart on France - Year-over-year growth 2023-2028 (%)
- Data Table on France - Year-over-year growth 2023-2028 (%)

11.14 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)

11.15 Australia - Market size and forecast 2023-2028
- Chart on Australia - Market size and forecast 2023-2028 ($ million)
- Data Table on Australia - Market size and forecast 2023-2028 ($ million)
- Chart on Australia - Year-over-year growth 2023-2028 (%)
- Data Table on Australia - Year-over-year growth 2023-2028 (%)

11.16 Brazil - Market size and forecast 2023-2028
- Chart on Brazil - Market size and forecast 2023-2028 ($ million)
- Data Table on Brazil - Market size and forecast 2023-2028 ($ million)
- Chart on Brazil - Year-over-year growth 2023-2028 (%)
- Data Table on Brazil - Year-over-year growth 2023-2028 (%)

11.17 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)

12 Drivers, Challenges, and Opportunity/Restraints

12.1 Market drivers

12.2 Market challenges

12.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028

12.4 Market opportunities/restraints

13 Competitive Landscape

13.1 Overview

13.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation

13.3 Landscape disruption
- Overview on factors of disruption

13.4 Industry risks
- Impact of key risks on business

14 Competitive Analysis

14.1 Companies profiled
- Companies covered

14.2 Company ranking index
- Company ranking index

14.3 Market positioning of companies
- Matrix on companies position and classification

14.4 AbbVie Inc.
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
- SWOT

14.5 Alfasigma Spa
- Alfasigma Spa - Overview
- Alfasigma Spa - Product / Service
- Alfasigma Spa - Key offerings
- SWOT

14.6 Astellas Pharma Inc.
- Astellas Pharma Inc. - Overview
- Astellas Pharma Inc. - Product / Service
- Astellas Pharma Inc. - Key offerings
- SWOT

14.7 AstraZeneca Plc
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product / Service
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
- SWOT

14.8 Bausch Health Companies Inc.
- Bausch Health Companies Inc. - Overview
- Bausch Health Companies Inc. - Business segments
- Bausch Health Companies Inc. - Key news
- Bausch Health Companies Inc. - Key offerings
- Bausch Health Companies Inc. - Segment focus
- SWOT

14.9 Bayer AG
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key news
- Bayer AG - Key offerings
- Bayer AG - Segment focus
- SWOT

14.10 Boehringer Ingelheim International GmbH
- Boehringer Ingelheim International GmbH - Overview
- Boehringer Ingelheim International GmbH - Product / Service
- Boehringer Ingelheim International GmbH - Key news
- Boehringer Ingelheim International GmbH - Key offerings
- SWOT

14.11 Ironwood Pharmaceuticals Inc
- Ironwood Pharmaceuticals Inc - Overview
- Ironwood Pharmaceuticals Inc - Product / Service
- Ironwood Pharmaceuticals Inc - Key offerings
- SWOT

14.12 Mallinckrodt Plc
- Mallinckrodt Plc - Overview
- Mallinckrodt Plc - Business segments
- Mallinckrodt Plc - Key news
- Mallinckrodt Plc - Key offerings
- Mallinckrodt Plc - Segment focus
- SWOT

14.13 Nestle Health Science S.A.
- Nestle Health Science S.A. - Overview
- Nestle Health Science S.A. - Product / Service
- Nestle Health Science S.A. - Key offerings
- SWOT

14.14 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT

14.15 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- SWOT

14.16 Sanofi SA
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
- SWOT

14.17 Sebela Pharmaceuticals Inc.
- Sebela Pharmaceuticals Inc. - Overview
- Sebela Pharmaceuticals Inc. - Product / Service
- Sebela Pharmaceuticals Inc. - Key offerings
- SWOT

14.18 Takeda Pharmaceutical Co. Ltd.
- Takeda Pharmaceutical Co. Ltd. - Overview
- Takeda Pharmaceutical Co. Ltd. - Product / Service
- Takeda Pharmaceutical Co. Ltd. - Key news
- Takeda Pharmaceutical Co. Ltd. - Key offerings
- SWOT

15 Appendix